Find a Clinical Trial
Filter
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
Recruiting now
Department of Medicine, Cancer Center
BoppliTM blood pressure monitoring
Neonatal care
All genders
Recruiting now
Department of Pediatrics
ELGAN 3
Premature babies, Premature birth
All genders
Recruiting now
Department of Pediatrics
ROACTIVE-HF II
Heart failure
All genders
Recruiting now
Division of Cardiology
PICU-SSI
Intensive care
All genders
No minimum age
Recruiting now
Department of Pediatrics
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
Bladder cancer
All genders
Recruiting now
Department of Urology
Automated Screening for Aortic Stenosis
Aortic stenosis, Structural heart disease
All genders
Recruiting now
CardioVascular Center